Nintedanib versus placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: TRICC-C trial—Final results from the randomized phase II trial of the AIO. This is an ASCO ...
Utility of a Clinically Guided Data-Driven Approach for Predicting Breast Cancer Complications: An Application Using a Population-Based Claims Data Set Performing a geriatric assessment as part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback